Highlights
• By analyzing data from a multicenter cluster-randomised controlled trial (n = 2772), we provide insights into optimal early protein delivery in critically ill patients with various AKI stages.
• Overall, in critically ill patients, increased early protein delivery (up to close to the guideline recommendation) was significantly associated with a reduction in 28-day mortality.
• Early protein delivery and 28-day mortality significantly interacted with baseline AKI stages. Increased early protein delivery was only associated with reduced 28-day mortality in patients without AKI and with AKI stage Ⅲ, but not in those with AKI stage Ⅰ or Ⅱ.
• More high-quality evidence is needed to evaluate the role of renal function in protein delivery in critically ill patients.
京公网安备11010802044758号
Comments on this article